Elanco Animal Health Incorporated
ELAN
$9.57
$0.1051.11%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.45% | -3.56% | 12.02% | -4.14% | 5.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.45% | -3.56% | 12.02% | -4.14% | 5.08% |
| Cost of Revenue | -2.91% | 1.03% | 14.06% | 4.25% | 15.18% |
| Gross Profit | 0.00% | -7.40% | 10.59% | -9.57% | -3.35% |
| SG&A Expenses | 2.44% | 3.19% | 0.28% | 3.06% | -3.04% |
| Depreciation & Amortization | -5.80% | -5.00% | -3.68% | -0.75% | 6.15% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.37% | 0.88% | 6.47% | 3.47% | 6.92% |
| Operating Income | -6.67% | -111.90% | 116.98% | -39.82% | -51.61% |
| Income Before Tax | 59.84% | 150.96% | 59.49% | -88.89% | -42.70% |
| Income Tax Expenses | -407.14% | 19,600.00% | 0.00% | -500.00% | 140.00% |
| Earnings from Continuing Operations | 94.33% | 133.21% | 48.45% | -68.93% | -161.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 94.33% | 133.21% | 48.45% | -68.93% | -161.11% |
| EBIT | -6.67% | -111.90% | 116.98% | -39.82% | -51.61% |
| EBITDA | 4.55% | -23.26% | 20.43% | -24.11% | -1.49% |
| EPS Basic | 94.34% | 133.10% | 48.60% | -69.05% | -158.91% |
| Normalized Basic EPS | 44.18% | -63.43% | 264.95% | -60.99% | -34.23% |
| EPS Diluted | 93.26% | 132.82% | 49.40% | -71.39% | -162.99% |
| Normalized Diluted EPS | 44.18% | -62.42% | 264.95% | -61.05% | -34.23% |
| Average Basic Shares Outstanding | 0.32% | 0.32% | 0.32% | 0.43% | 0.88% |
| Average Diluted Shares Outstanding | 0.32% | 1.01% | 0.32% | 0.65% | 0.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |